業績一覧
２０２５年度
原著論文
Hara Y, Tanabe N, Marumo S, Murohashi K, Hayashi Y, Nagata M, Asada T, Nagaoka S, Kobayashi N, Hirai T, Kaneko T. Clinical Impact of Mepolizumab on Airway Mucus Plugs in Patients with Severe Asthma. J Asthma Allergy. 18: 1713-1725, 2025.
Somekawa K, Horita N, Nagaoka S, Kajita Y, Muraoka S, Izawa A, Otsu Y, Kaneko A, Hirata M, Inoue R, Kubo S, Tanaka K, Nagasawa R, Yagyu H, Murohashi K, Aoki A, Kameda Y, Fujii H, Watanabe K, Hara Y, Adachi H, Kobayashi N, Saito A, Kaneko T. Valid surrogate end-points in nonsmall cell lung cancer peri-operative systemic therapy trials: a systematic review. Eur Respir Rev. 34(178): 250034, 2025.
Nishimura M, Kitamura H, Tagami Y, Fujimoto K, Fukushima T, Otoshi R, Niwa T, Aoki J, Fukuda T, Sawazumi T, Iwasawa T, Okudela K, Takemura T, Natsume-Kitatani Y, Hara Y, Kaneko T, Ogura T. Familial fibrotic hypersensitivity pneumonitis: A distinct clinical phenotype with shorter leukocyte telomere length. Respir Investig. 63(6): 1338-1346, 2025.
Yagyu H, Kiuchi M, Sasaki A, Itakura E, Kokubo K, Iwamura C, Onodera A, Aoki A, Hishiya T, Tsuji K, Hiramoto T, Shinmi R, Sonobe Y, Arano T, Ohishi K, Baba S, Kurita J, Iinuma T, Yonekura S, Hara Y, Kimura MY, Motohashi S, Tumes DJ, Hanazawa T, Kaneko T, Nakayama T, Hirahara K. Lipolysis-microlipophagy cascade regulated by adipose triglyceride lipase drives pathogenic adaptive type 2 immunity. Sci Immunol. 10(112): eadp0849, 2025.
Ogawa F, Somekawa K, Yabe A, Nishii M, Okada H, Takada C, Kaneko T, Takeuchi I. Insights into the effects of inhaled drugs on airway epithelium with human airway basal cells. Biochem Biophys Res Commun. 783: 152634, 2025.
Muraoka S, Kobayashi N, Kaneko A, Somekawa K, Kajita Y, Hirose T, Tanaka A, Teranishi S, Miura K, Yumoto K, Tsukahara T, Fukuda N, Nishihira R, Horita N, Hara Y, Kudo M, Miyazawa N, Kaneko T. Real-world efficacy of immune checkpoint inhibitors in PD-L1 negative non-small cell lung cancer: a multicenter retrospective study. Transl Lung Cancer Res. 14(7): 2636-2645, 2025.
Kaneko A, Kobayashi N, Kubo S, Nagaoka S, Muraoka S, Fukuda N, Somekawa K, Matsumoto H, Katakura S, Teranishi S, Watanabe K, Horita N, Hara Y, Kudo M, Kaneko T. MiR-200a regulates PD-L1 and predicts response to immune checkpoint inhibitors in advanced non-small cell lung cancer. Transl Lung Cancer Res. 14(7): 2522-2536, 2025.
Nishimura M, Sekine A, Inafuku K, Moriuchi A, Tagami Y, Ikeda S, Oda T, Misumi T, Arai H, Baba T, Komatsu S, Hagiwara E, Iwasawa T, Kaneko T, Ogura T. Incidence and risk factors of unilateral upper-lung field pulmonary fibrosis radiologically consistent with pleuroparenchymal fibroelastosis after lung cancer surgery in interstitial lung disease patients. Respir Investig. 63(5): 983-990, 2025.
Nagaoka S, Yamamoto M, Takakura S, Okazaki S, Nakadegawa R, Suzukawa Y, Tanaka A, Matsushita S, Muraoka T, Maeda C, Hirose T, Seki K, Teranishi S, Tashiro K, Kudo M, Kaneko T. Reduction of post-bronchoscopy pneumonia by working channel irrigation with sterile saline before diagnostic procedures. BMC Pulm Med. 25(1): 243, 2025.
Takahashi S, Tanabe N, Marumo S, Hara Y, Hayashi Y, Tsukamoto S, Morita K, Yoshimura C, Hwang MH, Sunadome H, Sato A, Murohashi K, Kaneko T, Matsumoto H, Hirai T. Exploring factors associated with clinical remission in patients with severe asthma receiving anti-IL-4Rα, anti-IL-5/5R, or anti-IgE treatment. Respir Investig. 63(4): 633-638, 2025.
Suzukawa Y, Teranishi S, Takakura S, Nakadegawa R, Okazaki S, Tanaka A, Matsushita S, Muraoka T, Hirose T, Maeda C, Seki K, Tashiro K, Kobayashi N, Yamamoto M, Kudo M, Kaneko T. Efficacy and safety of intrapleural administration of sodium bicarbonate in patients with acute empyema and complicated parapneumonic effusion: protocol for a prospective, single-arm, interventional study. BMC Infect Dis. 25(1): 580, 2025.
Somekawa K, Kobayashi N, Nagaoka S, Seki K, Kajita Y, Muraoka S, Izawa A, Kaneko A, Otsu Y, Hirata M, Kubo S, Nagasawa R, Murohashi K, Fuji H, Teranishi S, Tashiro K, Watanabe K, Horita N, Hara Y, Kudo M, Kaneko T. Rapid detection of non-small cell lung cancer driver mutations using droplet digital polymerase chain reaction analysis of bronchial washings: a prospective multicenter study. Transl Lung Cancer Res. 14(2): 353-362, 2025.
Tamaoki J, Nagase H, Sano H, Kaneko T, Gon Y, Miyahara N, Sagara H, Tanaka A, Horiguchi T, Tagaya E, Akaba T, Tohda Y. Practical Guidelines for Asthma Management (PGAM): Digest edition. PGAM committee in the Japan Asthma Society. Respir Investig. 63(3): 405-421, 2025.
Chen H, Zhang S, Matsumoto H, Tsuchiya N, Yamada C, Okasaki S, Miyasaka A, Yumoto K, Kanou D, Kashizaki F, Koizumi H, Takahashi K, Shimizu M, Horita N, Kaneko T. Employing a low-code machine learning approach to predict in-hospital mortality and length of stay in patients with community-acquired pneumonia. Sci Rep. 15: 309, 2025.
Atsuta R, Fujii H, Hara Y, Tanaka H, Nakamura K, Obase Y, Haranaga S, Takahashi H, Shinkai M, Terada J, Ikari J, Katsura H, Yamamoto K, Suzuki T, Tagaya E, Hozawa S, Mukae H, Kaneko T. Causative diseases of bloody sputum and hemoptysis in respiratory clinics in Japan. Respir Investig. 63(1): 156-162, 2025.
Decreased Hemithorax in an Adult. Kashizaki F, Chen H, Tsuchiya N, Matsumoto S, Osada R, Miyasaka A, Kaneko M, Kikuchi A, Kojima Y, Yumoto K, Hashiyama N, Osawa H, Koizumi H, Mo M, Takahashi K, Kaneko T. Clinical Features of Primary Pulmonary Artery Sarcoma: A Systematic Review and Pooled Analysis. Arch Bronconeumol. 61(9): 536-543, 2025.
英文総説
Kashizaki F, Chen H, Tsuchiya N, Matsumoto S, Osada R, Miyasaka A, Kaneko M, Kikuchi A, Kojima Y, Yumoto K, Hashiyama N, Osawa H, Koizumi H, Mo M, Takahashi K, Kaneko T. Clinical Features of Primary Pulmonary Artery Sarcoma: A Systematic Review and Pooled Analysis. Arch Bronconeumo. 61(9): 536-543, 2025.
和文総説
金子 猛: 特集 なかなか治らない厄介な咳. 《総論》遷延性咳嗽，慢性咳嗽とは. 耳鼻咽喉科・頭頸部外科, 97(13): 1062-1066, 2025.
金子 猛: 重症喘息治療の新展開 気道粘液栓の病態と治療戦略. 神奈川医学会雑誌, 52(2): 17-29, 2025.
金子 猛: 【気管支拡張症(非嚢胞性線維症性)】気管支拡張症 疫学と予後. 呼吸器内科, 48(3): 240-243, 2025.
柳生 洋行, 原 悠, 金子 猛: 【-知ってるつもり? 知らなきゃいけない?-新語・新概念辞典】新語・新概念(五十音順) (気管支喘息の)臨床的寛解. 総合診療, 35(2): 164, 2025.
村岡 傑, 小林 信明, 金子 猛: 【-知ってるつもり? 知らなきゃいけない?-新語・新概念辞典】新語・新概念(五十音順) (肺がん治療における)免疫チェックポイント阻害薬(ICI). 総合診療, 35(2): 162-163, 2025.
金子 猛: 【-知ってるつもり? 知らなきゃいけない?-新語・新概念辞典】新語・新概念(五十音順) 中枢気道粘液栓/粘液スコア. 総合診療, 3(2): 147-148, 2025.
原 悠, 金子 猛: 【-知ってるつもり? 知らなきゃいけない?-新語・新概念辞典】新語・新概念(五十音順) 進行性線維化を伴う間質性肺疾患(PF-ILD). 総合診, 3(2): 141, 2025.
金子 猛: 呼吸器疾患診療の最新情報（II）痰. ドクターサロン, 69(8): 490-493, 2025.
学会発行診療ガイドライン等
金子 猛(喀痰部門作成委員長): 日本呼吸器学会咳嗽・喀痰の診療ガイドライン2025作成委員会（編）：咳嗽・喀痰の診療ガイドライン第2版2025.東京：メデイカルレビュー社；2025. Takeshi Kaneko (Member of the Guideline Development Committee): Practical Guidelines for Asthma Management (PGAM): Digest edition. PGAM committee in the Japan Asthma Society (Tamaoki J, Nagase H, Sano H, Kaneko T, Gon Y, Miyahara N, Sagara H, Tanaka A, Horiguchi T, Tagaya E, Akaba T, Tohda Y). Respir Investig. 63(3): 405-421, 2025.
著書
金子 猛: 慢性閉塞性肺疾患COPDオーバーラップ(ACO). 今日の治療指針2025. 医学書院, 289-294, 2025.
長澤 遼, 原 悠, 金子 猛: 【改訂版 同効薬、納得の使い分けUpdate 最新の根拠を学び、症例で鍛え、ピットフォールを回避する】(第3章)呼吸器の薬の使い分け 鎮咳薬・喀痰調整薬の使い分け. レジデントノート, 27(2): 257-261, 2025.
金子 猛: 【改訂版 同効薬、納得の使い分けUpdate 最新の根拠を学び、症例で鍛え、ピットフォールを回避する】(第3章)呼吸器の薬の使い分け 総論. レジデントノート, 27(2): 239-242, 2025.
症例報告
Watanabe K, Kaneko T. Decreased Hemithorax in an Adult. JMA J. 8(4):1416-1417, 2025.
Kodama Y, Oshikata C, Terada K, Yamashita Y, Nakadegawa R, Masumitsu H, Motobayashi Y, Osada R, Takayasu H, Masumoto N, Kaneko T, Tsurikisawa N. Environmental intervention for two cases of non-tuberculous mycobacterial disease. Nagoya J Med Sci. 87(2): 351-359, 2025.
Invited Lecture
Kaneko T: Pathophysiology and Therapeutic Strategies for Airway Mucus Hypersecretion in Asthma. The Korean Academy of Tuberculosis and Respiratory Diseases International Conference 2025, Soul, 2025, 10.
Kaneko T：Pathophysiology and Therapeutic Strategies for Airway Mucus Plugging in Asthma. Tianjin Respiratory Specialty Alliance Academic Annual Meeting. Tianjin, 2025,7.
特別講演・教育講演・シンポジウム等
金子 猛: ＜シンポジウム＞6年ぶりに改訂された「咳嗽・喀痰の診療ガイドライン2025」のポイントを学ぶ「喀痰セクションのポイント一気読み」. 第65回日本呼吸器学会学術講演会, 東京, 2025, 4.
２０２４年度
原著論文
1. Kobayashi N, Katakura S, Fukuda N, Somekawa K, Kaneko A, Kaneko T. The Impact of Bevacizumab and miR200c on EMT and EGFR-TKI Resistance in EGFR-Mutant Lung Cancer Organoids. Genes (Basel). 15(12): 1624. 2024.
2. Kobayashi N, Matsumoto H, Kaneko T. Dissecting regional variability in Pyrazinamide prescribing practices for tuberculosis treatment in Japan. J Clin Tuberc Other Mycobact Dis. 37: 100497, 2024.
3. Tanaka A, Teranishi S, Kajita Y, Hirose T, Kaneko A, Sairenji Y, Kawashima H, Yumoto K, Tsukahara T, Miura K, Kobayashi N, Yamamoto M, Nishihira R, Kudo M, Miyazawa N, Nishikawa M, Kaneko T. Total baseline tumor size predicts survival among patients with advanced small-cell lung cancer receiving chemotherapy plus programmed death-ligand 1 inhibitor as first-line therapy: a multicenter retrospective observational study. Front Oncol. 14: 1400277, 2024.
4. Tanabe N, Hara Y, Shimizu K, Marumo S, Miyata J, Morita K, Watanabe T, Oishi K, Yamaguchi M, Asai K, Nakano Y, Hirano T, Matsunaga K, Koya T, Matsumoto H, Fukunaga K, Konno S, Kaneko T, Hirai T. A protocol for a Japanese prospective cohort evaluating the features of patients with uncontrolled asthma achieving clinical remission: J-CIRCLE. Respir Investig. 62(6): 1209-1214, 2024.
5. Matsumoto H, Fukushima T, Kobayashi N, Higashino Y, Muraoka S, Ohtsu Y, Hirata M, Somekawa K, Kaneko A, Nagasawa R, Kubo S, Tanaka K, Murohashi K, Fujii H, Watanabe K, Horita N, Hara Y, Kaneko T. High red blood cell distribution width attenuates the effectiveness of Immune checkpoint inhibitor therapy: An exploratory study using a clinical data warehouse. PLoS One. 19(8): e0299760, 2024.
6. Somekawa K, Watanabe K, Seki K, Muraoka S, Izawa A, Kaneko A, Otsu Y, Hirata M, Kubo S, Tanaka K, Nagasawa R, Matsumoto H, Murohashi K, Fuji H, Aoki A, Horita N, Hara Y, Kobayashi N, Kudo M, Kaneko T. Efficacy and safety of benralizumab in elderly patients with severe eosinophilic asthma. Eur Clin Respir J. 11(1): 2384173, 2024.
7. Kobayashi N, Tanaka K, Muraoka S, Somekawa K, Kaneko A, Kubo S, Matsumoto H, Fujii H, Watanabe K, Horita N, Hara Y, Kaneko T: Influence of age, IGRA results, and inflammatory markers on mortality in hospitalized tuberculosis patients. J Infect Chemother. 30(1): 48-52, 2024.
8. Hirata M, Hara Y, Fujii H, Murohashi K, Saigusa Y, Zhao S, Kobayashi M, Nagasawa R, Tagami Y, Izawa A, Otsu Y, Watanabe K, Horita N, Kobayashi N, Kaneko T: ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases. BMC Pulm Med. 24(1): 16, 2024.
9. Fukuda Y, Horita N, Aga M, Kashizaki F, Hara Y, Obase Y, Niimi A, Kaneko T, Mukae H, Sagara H: Efficacy and safety of macrolide therapy for adult asthma: A systematic review and meta-analysis. Respir Investig. 62(2): 206-215, 2024.
10. Izawa A, Hara Y, Horita N, Muraoka S, Kaneko M, Kaneko A, Somekawa K, Hirata M, Otsu Y, Matsumoto H, Nagasawa R, Tanaka K, Kubo S, Murohashi K, Aoki A, Fujii H, Watanabe K, Kobayashi N, Miura K, Nakajima H, Kaneko T: Improved diagnostic accuracy with three lung tumor markers compared to six-marker panel. Transl Lung Cancer Res. 13(3): 503-511, 2024.
11. Yamada K, Takeuchi M, Fukumoto T, Suzuki M, Kato A, Mizuki Y, Yamada N, Kaneko T, Mizuki N, Horita N: Immune checkpoint inhibitors for metastatic uveal melanoma: a meta-analysis. Sci Rep. 14(1): 7887, 2024.
12. Fujii H, Hara Y, Obase Y, Haranaga S, Takahashi H, Shinkai M, Terada J, Ikari J, Katsura H, Yamamoto K, Suzuki T, Tagaya E, Mukae H, Kaneko T: Nationwide survey in Japan of the causative diseases of bloody sputum and hemoptysis in departments of respiratory medicine at university hospitals and core hospitals. Respir Investig. 62(3): 395-401, 2024.
13. Kaneko A, Kobayashi N, Miura K, Matsumoto H, Somekawa K, Hirose T, Kajita Y, Tanaka A, Teranishi S, Sairenji Y, Kawashima H, Yumoto K, Tsukahara T, Fukuda N, Nishihira R, Watanabe K, Horita N, Hara Y, Kudo M, Miyazawa N, Kaneko T: Real-world evidence of efficacy of pembrolizumab plus chemotherapy and nivolumab plus ipilimumab plus chemotherapy as initial treatment for advanced non-small cell lung cancer. Thorac Cancer. 15(15): 1208-1217, 2024.
14. Tagami Y, Horita N, Kaneko M, Muraoka S, Fukuda N, Izawa A, Kaneko A, Somekawa K, Kamimaki C, Matsumoto H, Tanaka K, Murohashi K, Aoki A, Fujii H, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Whole-Genome Sequencing Predicting Phenotypic Antitubercular Drug Resistance: Meta-analysis. J Infect Dis. 229(5): 1481-1492,2024.
15. Yamamoto S, Horita N, Hara J, Sasamoto M, Kanemitsu Y, Hara Y, Obase Y, Kaneko T, Niimi A, Mukae H. Benefit-Risk Profile of P2X3 Receptor Antagonists for Treatment of Chronic Cough: Dose-Response Model-Based Network Meta-Analysis. Chest. 166(5): 1124-1140, 2024.
16. Kashizaki F, Konishi K, Chen H, Tanaka A, Miyasaka A, Okazaki S, Yamada C, Tsuchiya N, Yumoto K, Koizumi H, Takahashi K, Kaneko T: Pretreatment asthma control test score as a predictive score for clinical remission after bronchial thermoplasty in younger patients with severe asthma and preserved lung function. J Asthma. 61(7): 663-670, 2024.
17. Kamata H, Takamatsu K, Fukunaga K, Chubachi S, Nakagawara K, Namkoong H, Terai H, Tanaka K, Sato S, Hagiwara E, Takei R, Kondoh Y, Takazono T, Hashimoto M, Tasaka S, Ohrui T, Tanino Y, Mineshita M, Komase Y, Miyazaki K, Nishikawa M, Ando A, Kita H, Ichihara E, Ohshimo S, Murata Y, Ishida M, Kobayashi S, Uchida T, Tateno H, Ikari J, Terashima T, Kozu Y, Tateishi T, Shinkai M, Sagara H, To Y, Ito Y, Yamamoto M, Yamamoto Y, Kita T, Ito Y, Tomii K, Fujita Y, Funaki Y, Yatera K, Yamasue M, Komiya K, Kozawa S, Manabe H, Hozumi H, Horiguchi T, Kitajima T, Nakano Y, Nagaoka T, Hojo M, Ebihara A, Kobayashi M, Takayama K, Jinta T, Sawai T, Fukuda Y, Kaneko T, Chin K, Ogura T, Mukae H, Ishii M, Yokoyama A: Pulmonary function and chest CT abnormalities 3 months after discharge from COVID-19, 2020-2021: A nation-wide multicenter prospective cohort study from the Japanese respiratory society. Respir Investig. 62(4): 572-579, 2024.
18. Tanaka K, Meguro A, Hara Y, Endo L, Izawa A, Muraoka S, Kaneko A, Somekawa K, Hirata M, Otsu Y, Matsumoto H, Nagasawa R, Kubo S, Murohashi K, Aoki A, Fujii H, Watanabe K, Horita N, Kato H, Kobayashi N, Takeuchi I, Nakajima A, Inoko H, Mizuki N, Kaneko T: HLA-DQA1*01:03 and DQB1*06:01 are risk factors for severe COVID-19 pneumonia. HLA. 104(1): e15609, 2024.
19. Kobayashi N, Matsumoto H, Somekawa K, Kaneko A, Fukuda N, Muraoka S, Ohtsu Y, Hirata M, Nagasawa R, Kubo S, Murohashi K, Fujii H, Aoki A, Watanabe K, Horita N, Hara Y, Kaneko T: Geographic and economic influences on benralizumab prescribing for severe asthma in Japan. Sci Rep. 14(1): 15190, 2024.
英文総説
1. Kashizaki F, Chen H, Miyasaka A, Tsuchiya N, Yamada C, Okazaki S, Kaneko M, Kano T, Kameda Y, Kikuchi A, Yumoto K, Osawa H, Koizumi H, Takahashi K, Kaneko T: Safety of Readministration of EGFR-TKI After Onset of Interstitial Lung Disease in Advanced EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis. Clin Lung Cancer. 25(1): e52-e57, 2024.
邦文総説
1. 柳生 洋行, 原 悠, 金子 猛: 【脳神経外科医が知っておくべき生活習慣病の最新治療】その他の生活習慣病と周辺疾患の基礎知識 脳神経外科診療で遭遇する慢性呼吸器疾患. Neurological Surgery, 52(6): 1224-1233, 2024.
2. 金子 猛: アレルギー用語解説シリーズ Mucus plug. アレルギー, 73(9): 1175-1176, 2024.
3. 金子 猛: 喀痰調整薬の使い分け. 呼吸器内科, 46(3):310-313, 2024.
4. 藤井 裕明, 原 悠, 金子 猛: 喘息・COPDにおけるMUC5ACとMUC5B. 呼吸器内科, 46(3):283-288, 2024.
5. 原 悠, 金子 猛: 【中枢気道粘液栓による閉塞性肺疾患病態のパラダイムシフト】閉塞性肺疾患(喘息・COPD)気道粘液栓の治療戦略. 呼吸器内科, 46(3):251-254, 2024.
学会発行診療ガイドライン等
1. 金子 猛(作成委員): 日本呼吸器学会: 喘息とCOPDのオーバーラップ（Asthma and COPD Overlap：ACO）診断と治療の手引き〔第2版〕2023, メディカルレビュー社, 2024.
2. 金子 猛(作成委員):日本アレルギー学会 喘息ガイドライン専門部会監. 喘息予防・管理ガイドライン2024. 東京：協和企画：2024.
3. 金子 猛(作成委員): 日本喘息学会: 喘息診療実践ガイドライン2024, 協和企画, 2024.
4. Takeshi Kaneko (Member of the Guideline Development Committee): Practical guide for the diagnosis and management of primary ciliary dyskinesia. Guideline Development Committee (Takeuchi K, Abo M, Date H, Gotoh S, Kamijo A, Kaneko T, Keicho N, Kodama S, Koinuma G, Kondo M, Masuda S, Mori E, Morimoto K, Nagao M, Nakano A, Nakatani K, Nishida N, Nishikido T, Ohara H, Okinaka Y, Sakaida H, Shiraishi K, Suzaki I, Tojima I, Tsunemi Y, Kainuma K, Ota N, Takeno S, Fujieda S); Auris Nasus Larynx, 51(3):553-568, 2024.
著書
1. 金子 猛: 咳嗽・喀痰. 日常診療に活かす診療ガイドラインUP-TO-DATE 2024-2025. メディカルレビュー社, 77-82, 2024.
2. 金子 猛: 喀痰. 今日の診断指針第9版. 医学書院, 300-302, 2024.
3. 原 悠, 金子 猛(編集): 呼吸器診療エッセンシャル. 南江堂, 2024.
4. 金子 猛: 【呼吸器疾患ペディア】各疾患 慢性気道疾患 気管支拡張症.日本医師会雑誌, 153巻特別号2 :S184-S186, 2024.
症例報告
1. Kashizaki F, Matsumoto S, Miyasaka A, Tsuchiya N, Osada R, Kaneko M, Yumoto K, Chen H, Konishi K, Koizumi H, Takahashi K, Kaneko T. Effectiveness of upfront triple oral combination therapy with additional pirfenidone in a patient with severe pulmonary hypertension associated with lung diseases. Respirol Case Rep. 12(8):e70010, 2024.
2. Osada R, Oshikata C, Kurihara Y, Terada K, Kodama Y, Yamashita Y, Nakadegawa R, Masumitsu H, Motobayashi Y, Takayasu H, Masumoto N, Manabe S, Zhu Y, Tanaka R, Kaneko T, Sasaki A, Tsurikisawa N: A Case of Type I Food Allergy Induced by Monosodium Glutamate. J Asthma Allergy, 17: 161-165, 2024.
3. Motobayashi Y, Oshikata C, Kodama Y, Terada K, Yamashita Y, Nakadegawa R, Masumitsu H, Osada R, Takayasu H, Masumoto N, Manabe S, Kaneko T, Shiraishi A, Tsurikisawa N: Intravenous cyclophosphamide and immunoglobulin ameliorated visual field defects in a patient with eosinophilic granulomatosis with polyangiitis. Respir Med Case Rep, 47: 101980, 2024.
4. Yamada C, Kashizaki F, Kaneko M, Kitaji D, Kawano N, Kaneko T: Hemodialysis requirement after the first dose of durvalumab following chemoradiation therapy: a case report. Anticancer Drugs, 35(2): 199-202, 2024.
5. Kashizaki F, Konishi K, Yamada C, Okazaki S, Chen H, Miyasaka A, Tsuchiya N, Kikuchi A, Yumoto K, Kojima Y, Osawa H, Koizumi H, Takahashi K, Kaneko T: Successful excision of an inflammatory endobronchial polyp using biopsy forceps with improvement in FEV1 in a patient with allergic bronchopulmonary aspergillosis: A case report. Respir Med Case Rep, 48: 102011, 2024.
6. Kaneko T, Sekine A, Komatsu S, Otoshi R, Haga S, Tagami Y, Kaneko T, Ogura T: Successful pembrolizumab treatment for microsatellite instability-high thymoma: A case report. Respir Investig, 62(4): 517-519, 2024.
7. Yamashita Y, Terada K, Kodama Y, Nakadegawa R, Masumitsu H, Motobayashi Y, Osada R, Takayasu H, Masumoto N, Kaneko T, Tsurikisawa N. Tezepelumab improved chronic rhinosinusitis with nasal polyps in a Patient with aspirin exacerbated respiratory disease. Respir Med Case Rep, 50: 102041, 2024.
8. 金子 恵, 田上 陽一, 原 悠, 田村 祐規, 南 ひろこ, 金子 猛: 肺腺癌の副腎転移との鑑別に苦慮した副腎皮質癌の1例. 日本呼吸器学会誌, 13(4), 184-188, 2024.
9. 渡邉 恵介, ゴルベヴ 美菜子, 川田 博, 岡田 秀雄, 金子 猛: メポリズマブが長期間安全に使用し得た,超高齢者難治性好酸球性喘息の1例. 診断と治療, 112(6): 791-794, 2024.
特別講演・教育講演・シンポジウム等
1. 金子 猛: ＜イブニングシンポジウム＞「Better Breathingを目指した気道粘液過分泌に対する治療戦略」. 第74回日本アレルギー学会学術大会, 東京, 2024, 10.
2. 金子 猛: ＜教育講演＞「重症喘息治療の新展開～気道粘液過分泌のインパクト～」. 第 70回 日本内科学会四国支部 生涯教育講演会, 徳島, 2024, 6.
3. 金子猛: ＜会長講演＞「呼吸器病学の新しい時代、明るい未来に向けて」. 第64回日本呼吸器学会学術講演会, 横浜, 2024, 4.
4. 金子猛: ＜シンポジウム＞咳嗽喀痰の診療ガイドライン「喘息およびCOPDにおける中枢気道粘液栓について」. 第64回日本呼吸器学会学術講演会, 横浜, 2024, 4.
２０２３年度
原著論文
1． Kimura Y, Shinoda M, Shinkai M, Kaneko T: Solithromycin inhibits IL-13-induced goblet cell hyperplasia and MUC5AC, CLCA1, and ANO1 in human bronchial epithelial cells. PeerJ, 11: e14695, 2023.
2． Fujii H, Hara Y, Saigusa Y, Tagami Y, Murohashi K, Nagasawa R, Aoki A, Izawa A, Seki K, Watanabe K, Horita N, Kobayashi N, Kaneko T: ILD-GAP Combined with the Charlson Comorbidity Index Score (ILD-GAPC) as a Prognostic Prediction Model in Patients with Interstitial Lung Disease. Can Respir J, 2023: 5088207, 2023.
3． Nagasawa R, Hara Y, Murohashi K, Saigusa Y, Nishikawa Y, Tanaka M, Aoki A, Tagami Y, Kobayashi N, Kudo M, Kaneko T: Additional Efficacy of Macrolide for Patients with Acute Deterioration of Interstitial Lung Disease Requiring Corticosteroid Pulse Therapy. Am J Ther, 30(2): 170-173, 2023.
4． Honda Y, Yoneda M, Kobayashi T, Iwaki M, Kawamura N, Nogami A, Kessoku T, Ogawa Y, Tomeno W, Imajo K, Horita N, Saito S, Kaneko T, Nakajima A: Meta-analysis of the diagnostic accuracy of serum type IV collagen 7S concentration for the staging of liver fibrosis in nonalcoholic fatty liver disease. Hepatol Res, 53(3): 219-227, 2023.
5． Matsumoto H, Kobayashi N, Shinoda S, Goto A, Kaneko A, Fukuda N, Kamimaki C, Kubo S, Watanabe K, Horita N, Hara Y, Ishikawa Y, Kaneko T: Regional differences in epidermal growth factor receptor-tyrosine kinase inhibitor therapy in lung cancer treatment using a national database in Japan. Sci Rep, 13(1): 5208, 2023.
6． Watanabe K, Horita N, Hara Y, Kobayashi N, Kaneko T: Clinical features of asthma with connective tissue diseases. Clin Respir J, 17(4): 303-310, 2023.
7． Masumoto N, Oshikata C, Nakadegawa R, Motobayashi Y, Osada R, Manabe S, Kaneko T, Tsurikisawa N: Long-term mepolizumab treatment reduces relapse rates in super-responders with eosinophilic granulomatosis with polyangiitis. Allergy Asthma Clin Immunol, 19(1): 40, 2023.
8． Kata Y, Hara Y, Murohashi K, Saigusa Y, Nagasawa R, Tagami Y, Fujii H, Aoki A, Nishikawa Y, Tanaka K, Watanabe K, Horita N, Kobayashi N, Yamamoto M, Kudo M, Kaneko T: ＜Editors' Choice＞ Comparison of clinical features between patients with acute exacerbation of idiopathic interstitial pneumonia and collagen vascular disease-associated interstitial pneumonia. Nagoya J Med Sci, 85(3): 602-611, 2023.
9． Chen H, Yumoto K, Kashizaki F, Koizumi H, Ikeda I, Horita N, Takahashi K, Kaneko T: KEYNOTE-407: an effective and safe first-line treatment option for metastatic squamous non-small cell lung cancer. Transl Lung Cancer Res, 12(8): 1830-1833, 2023.
10． Hirama N, Yamamoto M, Nagaoka S, Segawa W, Sugimoto C, Nagayama H, Hiro S, Kajita Y, Maeda C, Kubo S, Seki K, Nagahara Y, Teranishi S, Tashiro K, Hara Y, Kobayashi N, Watanabe S, Kudo M, Kaneko T: Predictors of lung injury during durvalumab maintenance therapy following concurrent chemoradiotherapy in unresectable locally advanced non-small cell lung carcinoma. Thorac Cancer, 14(25): 2601-2607, 2023.
11． Hamakawa Y, Agemi Y, Shiba A, Ikeda T, Higashi Y, Aga M, Miyazaki K, Taniguchi Y, Misumi Y, Nakamura Y, Shimokawa T, Saigusa Y, Kobayashi N, Okamoto H, Kaneko T: Association of PD-L1 tumor proportion score ≥20% with early resistance to osimertinib in patients with EGFR-mutated NSCLC. Cancer Med, 12(17): 17788-17797, 2023.
12． Matsumoto H, Somekawa K, Horita N, Ueda S, Kaneko M, Kaneko A, Fukuda N, Izawa A, Kamimaki C, Tanaka K, Murohashi K, Fuji H, Tagami Y, Aoki A, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Adverse events induced by durvalumab and tremelimumab combination regimens: a systematic review and meta-analysis. Ther Adv Med Oncol, 15: 17588359231198453, 2023.
13． Aoki A, Hara Y, Fujii H, Murohashi K, Nagasawa R, Tagami Y, Enomoto T, Matsumoto Y, Masuda M, Watanabe K, Horita N, Kobayashi N, Kudo M, Ogura T, Kaneko T: The clinical impact of comorbidities among patients with idiopathic pulmonary fibrosis undergoing anti-fibrotic treatment: A multicenter retrospective observational study. PLoS One, 18(9): e0291489, 2023.
14． Masumoto N, Kato S, Aichi M, Hasegawa S, Sahara K, Suyama K, Sano A, Miyazaki T, Okudela K, Kaneko T, Takahashi T: AMPAR receptor inhibitors suppress proliferation of human small cell lung cancer cell lines. Thorac Cancer, 14(29): 2897-2908, 2023.
15． Kajita Y, Teranishi S, Sawazumi T, Watanabe H, Nagaoka S, Tanaka A, Suzukawa Y, Motobayashi Y, Hirose T, Maeda C, Seki K, Tashiro K, Kobayashi N, Yamamoto M, Kudo M, Inayama Y, Kaneko T: Comparison of the slow-pull and aspiration methods of endobronchial ultrasound-guided transbronchial needle aspiration for next-generation sequencing-compatible tissue collection in non-small cell lung cancer. Cancer Med, 12(19): 19512-19522, 2023.
16． Kobayashi N, Miura K, Kaneko A, Matsumoto H, Somekawa K, Hirose T, Kajita Y, Tanaka A, Teranishi S, Sairenji Y, Kawashima H, Yumoto K, Tsukahara T, Fukuda N, Nishihira R, Kudo M, Miyazawa N, Kaneko T: Tailoring Therapeutic Strategies in Non-Small-Cell Lung Cancer: The Role of Genetic Mutations and Programmed Death Ligand-1 Expression in Survival Outcomes. Cancers (Basel), 15(21): 5248, 2023.
17． Nagasawa R, Niwa T, Hagiwara E, Oda T, Yamada S, Okuda R, Baba T, Komatsu S, Kaneko T, Ogura T: Safety and Efficacy of Combination Therapy of Remdesivir, Baricitinib, and High-dose Steroids in Patients Hospitalized with Moderate to Severe COVID-19. Intern Med, 62(21): 3125-3130, 2023.
18． Inoue S, Kata Y, Suido Y, Nakashima K, Otsu Y, Takayasu H, Matsumoto Y, Kaneko T: Limited efficacy of low-dose dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective study. Respir Investig, 61(6): 760-767, 2023.
19． Chen H, Kondo M, Horita N, Takahashi K, Kaneko T: The Complex Interaction between Proton Pump Inhibitors and Cancer Treatment. Cancers (Basel), 15(22): 5346, 2023.
20． Kubo S, Kobayashi N, Matsumoto H, Somekawa K, Kaneko A, Hashimoto H, Teranishi S, Watanabe K, Horita N, Hara Y, Kudo M, Kaneko T: Atezolizumab addition to platinum doublet: evaluating survival outcomes for patients with extensive disease small cell lung cancer. J Cancer Res Clin Oncol, 149(19): 17419-17426, 2023.
21． Tagami Y, Hara Y, Murohashi K, Nagasawa R, Fujii H, Izawa A, Yabe A, Saigusa Y, Kobayashi M, Shiida M, Hirata M, Otsu Y, Watanabe K, Horita N, Kobayashi N, Kaneko T: Serum heme oxygenase-1 as a prognostic biomarker in patients with acute exacerbation of interstitial lung disease. Sci Rep, 13(1): 22639, 2023.
英文総説
1． Fukuda N, Horita N, Kaneko A, Goto A, Kaneko T, Ota E, Kew KM: Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev, 6(6): CD012066, 2023.
2． Nakamura K, Fujita Y, Chen H, Somekawa K, Kashizaki F, Koizumi H, Takahashi K, Horita N, Hara Y, Muro S, Kaneko T: The Effectiveness and Safety of Long-Term Macrolide Therapy for COPD in Stable Status: A Systematic Review and Meta-Analysis. Diseases, 11(4): 152, 2023.
邦文総説
1. 井澤亜美, 原 悠, 金子 猛: 【咳の診断 これだけ読んで目星をつける】副鼻腔気管支症候群(解説). Allos Ergon, 3(1): 975-980, 2023.
2. 平田萌々, 原 悠, 金子 猛: 【慢性咳嗽2023】呼吸器疾患における咳嗽のメカニズムと対応 副鼻腔気管支症候群(解説). 呼吸器内科, 44(1): 67-71, 2023.
3. 芳賀 暁, 宇都宮大輔, 原 悠, 金子 猛: 【症例から学ぶ心臓血管放射線診断】腫瘍 心膜中皮腫(解説). 画像診断, 44(1): 72-73, 2023.
4. 藤井裕明, 原 悠, 金子 猛: 呼吸器内科専門医講座 呼吸器内科専門医のための模擬テスト7－解答と解説－. 呼吸器内科, 43(4): 471-474, 2023.
学会発行診療ガイドライン等
1. 金子 猛(作成委員): 日本呼吸器学会: 難治性喘息診断と治療の手引き〔第2版〕2023, メディカルレビュー社, 2023.
2. 金子 猛(作成委員): 日本喘息学会: 喘息診療実践ガイドライン2023, 協和企画, 2023.
3. 金子 猛(作成委員):日本鼻科学会: 線毛機能不全症候群の診療の手引き. 線毛機能不全症候群の診療の手引き作成委員会(太田 伸男, 竹野 幸夫, 竹内 万彦, 大原 浩達, 沖中 洋介, 上條 篤, 児玉 悟, 洲崎 勲夫, 常見 泰弘, 戸嶋 一郎, 仲野 敦子, 西田 直哉, 増田 佐和子, 森 恵莉, 坂井田 寛, 森本 耕三, 慶長 直人, 後藤 慎平, 近藤 光子, 阿保 未来, 金子 猛, 肥沼 悟郎, 錦戸 知喜, 長尾 みづほ, 中谷 中, 伊達 洋至, 白石 晃司, 藤枝 重治, 貝沼 圭吾).;日本鼻科学会会誌, 62(1):1-108, 2023.
著書
1. 金子 猛: 喘息・COPDオーバーラップ(ACO). 今日の治療指針2023. 医学書院, 295-297, 2023.
2. 金子 恵, 原 悠, 金子 猛: 慢性閉塞性肺疾患（COPD）. シーン別 内科病棟頻用薬の使い方. 日本医事新報社, 117-122, 2023.
3. 藤井裕明, 原 悠, 金子 猛: 去痰薬・鎮咳薬の選び方・用い方. 喘息・COPDと気道疾患包括診療マニュアル. 中外医学社, 98-109, 2023.
症例報告
1. Sakurai Y, Oshikata C, Katayama T, Takagi S, Kaneko Y, Yo K, Kaneko T, Kubota H, Matsubara T, Tsurikisawa N: A case of eosinophilic polyangiitis with granulomatosis that evolved to cardiac arrest due to advanced atrioventricular block. Nagoya J Med Sci, 85(1): 171-178, 2023.
2. Takayasu H, Kata Y, Otsu Y, Inoue S, Kaneko T: ALK-Rearranged NSCLC With Concomitant HER2-Mutant Breast Cancer Patient Treated With Alectinib, Trastuzumab, and Pertuzumab: A Case Report. Cureus, 15(3): e36711, 2023.
3. Watanabe K, Kobayashi N, Kaneko T: Recurrent Transient Asymptomatic Pulmonary Opacity with Long-Term Afatinib: A Case Report. Case Rep Oncol, 16(1): 167-171, 2023.
4. Sugimoto C, Teranishi S, Sawazumi T, Nagaoka S, Nagayama H, Segawa W, Hiro S, Kajita Y, Maeda C, Kubo S, Seki K, Tashiro K, Kobayashi N, Yamamoto M, Kudo M, Kaneko T: Primary tracheal small-cell carcinoma detected 11 months after surgery for pulmonary large-cell neuroendocrine carcinoma: A case report. Thorac Cancer, 14(13): 1212-1216, 2023.
5. Masumoto N, Oshikata C, Nakadegawa R, Motobayashi Y, Osada R, Manabe S, Kaneko T, Tsurikisawa N: Dupilumab suppresses relapsing chronic eosinophilic pneumonia with severe asthma. Nagoya J Med Sci, 85(4): 857-865, 2023.
6. Tanaka M, Oshikata C, Yamashita Y, Isono R, Nakadegawa R, Masumitsu H, Motobayashi Y, Osada R, Takayasu H, Masumoto N, Manabe S, Kaneko T, Ueno A, Tsurikisawa N: Eosinophilic granulomatosis with polyangiitis and severe cardiac involvement in a patient surviving for 34 years. J Asthma, 60(12): 2233-2242, 2023.
7. Watanabe K, Koji O, Matsumura M, Kaneko T: Post-COVID-19 Granulomatous inflammation in the lung, distinct from sarcoidosis: A report of two cases. Cureus, 15(12): e50821, 2023.
8. Hiro S, Teranishi S, Sawazumi T, Nagaoka S, Sugimoto C, Nagayama H, Segawa W, Kajita Y, Maeda C, Kubo S, Seki K, Tashiro K, Kobayashi N, Yamamoto M, Kudo M, Kaneko T: Thymic atypical carcinoid tumors with elevated mitotic counts in a patient with multiple endocrine neoplasia: A case report. Thorac Cancer, 14(14): 1311-1315, 2023.
特別講演・教育講演・シンポジウム等
1. 金子 猛: ＜特別講演＞「咳嗽・喀痰診療ガイドライン2024」. 第25回日本咳嗽学会学術大会, 栃木, 2023, 9.
2. 金子 猛: ＜特別講演＞喘息および COPD の病態理解のパラダイムシフト中枢気道粘液栓について. 第91回日本呼吸器学会・日本結核 非結核性抗酸菌症学会・ 日本サルコイドーシス／肉芽腫性疾患学会 九州支部秋季学術講演会, 宮崎, 2023, 10.
２０２２年度
原著論文
1. Watanabe K, Horita N, Hara Y, Kobayashi N, Kaneko T: Use of Systemic Corticosteroids for Reasons Other than Asthma in Subjects with Asthma. Respiration. 101(2): 109-115, 2022.
2. Fukuda N, Horita N, Namkoong H, Kaneko A, Somekawa K, Tagami Y, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Best regimens for treating chemo-naïve incurable squamous non-small cell lung cancer with a programmed death-ligand 1 tumor proportion score of 1%-49%: A network meta-analysis. Thorac Cancer. 13(1): 84-94, 2022.
3. Matsumoto H, Kobayashi N, Somekawa K, Fukuda N, Kaneko A, Kamimaki C, Kubo S, Tanaka K, Tagami Y, Teranishi S, Watanabe K, Horita N, Hara Y, Yamamoto M, Kudo M, Koizumi H, Miura K, Miyazawa N, Kaneko T: Pembrolizumab monotherapy versus pembrolizumab plus chemotherapy in patients with non-small-cell lung cancer: A multicenter retrospective trial. Thorac Cancer. 13(2): 228-235, 2022.
4. Horita N, Kato H, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Decline in mortality due to respiratory diseases in Japan during the coronavirus disease 2019 pandemic. Respirology. 27(2): 175-176, 2022.
5. Chen H, Katakura S, Horita N, Namkoong H, Kato I, Hara Y, Kobayashi N, Fujii S, Kaneko T: Immunohistochemical markers to diagnose primary squamous cell carcinoma of the lung: a meta-analysis of diagnostic test accuracy. Ther Adv Med Oncol. 14: 17588359211065152, 2022.
6. Somekawa K, Horita N, Kaneko A, Tagami Y, Fukuda N, Matsumoto H, Namkoong H, Fujiwara Y, Minegishi K, Fukumoto T, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Adverse events induced by nivolumab and ipilimumab combination regimens. Ther Adv Med Oncol. 14: 17588359211058393, 2022.
7. Oshikata C, Watanabe M, Hashimoto K, Yamazaki A, Kobayashi N, Konuma R, Ishida M, Kobayashi S, Shimada T, Kaneko T, Kamata Y, Kuriyama S, Kure S, Yanai M, Tsurikisawa N: Mite allergen avoidance decreases allergic symptoms in children in Ishinomaki city of Japan after natural disasters. Allergol Immunopathol (Madr). 50(2): 23-32, 2022.
8. Nagano A, Takeuchi M, Horita N, Teshigawara T, Kawagoe T, Mizuki Y, Meguro A, Nakano H, Kirino Y, Takase-Minegishi K, Yoshimi R, Kurosawa M, Fukumoto T, Takeno M, Kaneko T, Mizuki N: Behçet's disease and activities of daily living. Rheumatology(Oxford). 61(3): 1133-1140, 2022.
9. Doshita K, Kenmotsu H, Omori S, Tabuchi Y, Kawabata T, Kodama H, Nishioka N, Miyawaki E, Iida Y, Miyawaki T, Mamesaya N, Kobayashi H, Ko R, Wakuda K, Ono A, Naito T, Murakami H, Mori K, Harada H, Kaneko T, Takahashi T: Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysis. Invest New Drugs. 40(2): 411-419, 2022.
10. Horita N, Kato H, Watanabe K, Hara Y, Kobayashi N, Kaneko T: Declined Mortality Due to Seasonal Influenza in Japan During the Coronavirus Disease 2019 Pandemic. Clin Infect Dis. 74(11): 2081, 2022.
11. Mikami N, Takeda A, Hashimoto A, Takeda T, Kimura Y, Oku Y, Aoki Y, Eriguchi T, Tsurugai Y, Saeki N, Enomoto T, Kuribayashi H, Masuda M, Kaneko T: CT Findings and Treatment Outcomes of Ground-Glass Opacity Predominant Lung Cancer After Stereotactic Body Radiotherapy. Clin Lung Cancer. 23(5): 428-437, 2022.
12. Oshikata C, Watanabe M, Hashimoto K, Yamazaki A, Kobayashi N, Konuma R, Ishida M, Kobayashi S, Shimada T, Kaneko T, Kamata Y, Kuriyama S, Kure S, Yanai M, Tsurikisawa N: Effects of mite allergen avoidance in children in two distant towns in Japan. La Revue Française d'Allergologie. 62(8): 661-669, 2022.
13. Kata Y, Hara Y, Tagami Y, Yabe A, Murohashi K, Nagasawa R, Nakashima K, Fujii H, Saigusa Y, Shiida M, Watanabe K, Horita N, Kobayashi N, Kaneko T: Assessment of diagnostic utility of serum hemeoxygenase-1 measurement for acute exacerbation of interstitial pneumonias. Sci Rep. 12(1): 12935, 2022.
14. Hara Y, Tsukiji J, Yabe A, Onishi Y, Hirose H, Yamamoto M, Kudo M, Kaneko T, Ebina T: Heme oxygenase-1 as an important predictor of the severity of COVID-19. PLoS One. 17(8): e0273500, 2022.
15. Chen H, Hara Y, Horita N, Saigusa Y, Hirai Y, Kaneko T: Is rehabilitation effective in preventing decreased functional status after community-acquired pneumonia in elderly patients? Results from a multicentre, retrospective observational study. BMJ Open. 12(9): e051307, 2022.
16. Teranishi S, Sugimoto C, Nagaoka S, Nagayama H, Segawa W, Miyasaka A, Hiro S, Kajita Y, Maeda C, Kobayashi N, Yamamoto M, Kudo M, Kaneko T: Retrospective analysis of independent predictors of progression-free survival in patients with EGFR mutation-positive advanced non-small cell lung cancer receiving first-line Osimertinib. Thorac Cancer. 13(19): 2741-2750, 2022.
17. Fujii H, Nagakura H, Kobayashi N, Kubo S, Tanaka K, Watanabe K, Horita N, Hara Y, Nishikawa M, Miura K, Koizumi H, Ito Y, Tsubakihara M, Miyazawa N, Kudo M, Shinkai M, Kaneko T: Liquid biopsy for detecting epidermal growth factor receptor mutation among patients with non-small cell lung cancer treated with afatinib: a multicenter prospective study. BMC Cancer. 22(1): 1035, 2022.
18. Kato A, Horita N, Namkoong H, Nomura E, Masuhara N, Kaneko T, Mizuki N, Takeuchi M: Prophylactic antibiotics for postcataract surgery endophthalmitis: a systematic review and network meta-analysis of 6.8 million eyes. Sci Rep. 12(1): 17416, 2022.
19. Masumoto N, Watanabe K, Horita N, Hara Y, Kobayashi N, Kaneko T: Elderly sarcoidosis in Japan. J Int Med Res. 50(2): 3000605221142705, 2022.
20. Doshita K, Tabuchi Y, Kenmotsu H, Omori S, Kawabata T, Kodama H, Nishioka N, Miyawaki E, Iida Y, Mamesaya N, Kobayashi H, Ko R, Wakuda K, Ono A, Naito T, Murakami H, Mori K, Harada H, Kaneko T, Takahashi T: Incidence and Treatment Outcome of Radiation Pneumonitis in Patients With Limited-stage Small Cell Lung Cancer Treated With Concurrent Accelerated Hyperfractionated Radiation Therapy and Chemotherapy. Adv Radiat Oncol. 8(2): 101129, 2022.
21. 高橋浩一郎, 小林信明, 金子 猛: 呼吸器内科医の大学院進学とキャリア形成について, 日本呼吸器学会誌, 11(2): 128, 2022.
22. 住友みどり, 山崎悦子, 友山瑛人, 佐野加代子, 松永 智, 佐藤泰之, 川崎理加, 満田年宏, 金子 猛: 横浜市立大学附属病院における過去18年間の分離菌の抗菌薬感受性の検討. 横浜医学, 73(4): 517-527, 2022.
総説
1. 金子 猛: 【COPDと気管支喘息、その周辺疾患-病態・診断・治療の最新動向-】総論(COPDと気管支喘息) 咳嗽と喀痰から考えるCOPDと喘息. 日本臨床, 80(6): 21-26, 2022.
2. 金子彩美, 小林信明, 金子 猛: 臨床各科 難渋症例から学ぶ診療のエッセンス(File145) 免疫チェックポイント阻害薬による治療中に発症した肺結核. 日本医事新報, 5126: 12-13, 2022.
3. 田上陽一, 原 悠, 金子 猛: 臨床各科 難渋症例から学ぶ診療のエッセンス(File 141) ヘリコバクター・ピロリ除菌療法後に病変が消退した気管支原発MALTリンパ腫. 日本医事新報, 5120: 10-11, 2022.
4. 染川弘平, 小林信明, 金子 猛: 臨床各科 難渋症例から学ぶ診療のエッセンス(File 138) 新型コロナウイルスIgM抗体陽性で診断に苦慮した粟粒結核. 日本医事新報, 5116: 10-11, 2022.
5. 藤井裕明, 原 悠, 金子 猛: 臨床各科 難渋症例から学ぶ診療のエッセンス(File 134) 抗ヒトIL-6レセプターモノクローナル抗体投与中のPasteurella multocidaによる膿胸. 日本医事新報, 5111: 10-11, 2022.
6. 原 悠, 大島結女, 金子 猛: 臨床各科 難渋症例から学ぶ診療のエッセンス(File 148)新型コロナウイルス感染を契機に蜂巣肺病変の急速な拡大を認めた特発性肺線維症. 日本医事新報, 5129: 10-11, 2022.
7. 渡邉恵介, 原 悠, 金子 猛: 【重症気管支喘息治療のアップデート】合併症を有する気管支喘息 高齢者喘息. 呼吸器内科, 41(1): 55-60, 2022.
8. 原 悠, 金子 猛: 【喘息の発症メカニズムと治療・管理】診断と治療・管理 咳嗽と喀痰への対処. 医学のあゆみ, 281(1): 119-124, 2022.
9. 金子 猛: 【2022年なにあった?】Catch Up!新薬・新規効能・新剤形 TOPICS 新規作用機序の慢性咳嗽治療薬が登場! 薬局, 73(13): 3078-3081, 2022.
10. 金子 猛: 【COPD(慢性閉塞性肺疾患)診断と治療のためのガイドライン2022を読み解く】CQ「安定期のCOPDに対して,喀痰調整薬を推奨するか」について. 呼吸器内科, 42(4): 380-385, 2022.
11. 藤井裕明, 原 悠, 金子 猛: 喘息における喀痰治療薬と気道粘液過分泌に対する治療戦略. 呼吸器内科, 42(3): 323-329, 2022.
12. 金子 猛: 【難治性慢性咳嗽治療の新展開-ゲーファピキサントへの期待-】原因疾患別の診断と治療 最新のガイドラインを踏まえて 副鼻腔気管支症候群. Progress in Medicine, 42(6): 561-565, 2022.
学会発行診療ガイドライン
1. 金子 猛(責任編集委員): 日本呼吸器学会『COPD診断と治療のためのガイドライン2022[第6版]』, メディカルレビュー社, 2022.
2. 金子 猛(作成委員): 日本喘息学会: 『喘息診療実践ガイドライン2022』, 協和企画, 2022.
著書
1. 金子 猛: ニューモシスチス肺炎. 今日の治療指針2022. 医学書院, 229-230, 2022.
2. 金子 猛: 咳嗽・喀痰, 日常診療に活かす 診療ガイドラインUP-TO-DATE 2022-2023, メディカルレビュー社, 81-86, 2022.
3. 金子 猛, 原 悠: 呼吸機能検査による評価, 内科学, 朝倉書店, Ⅱ342-Ⅱ347, 2022.
症例報告
1. Adachi S, Oshikata C, Kaneko T, Tsurikisawa N: Rituximab and dupilumab improve eosinophilic granulomatosis with polyangiitis with multiple pulmonary thrombi. Allergy Asthma Clin Immunol. 18(1): 18, 2022.
2. Teranishi S, Sugimoto C, Nagayama H, Segawa W, Miyasaka A, Hiro S, Maeda C, Tamura H, Masumoto N, Nagahara Y, Hirama N, Kobayashi N, Yamamoto M, Kudo M, Kaneko T: Combination of Pembrolizumab With Platinum-containing Chemotherapy for Pulmonary Enteric Adenocarcinoma. Cancer Diagn Progn. 2(2): 253-257, 2022.
3. Otsu Y, Kata Y, Takayasu H, Inoue S, Kaneko T: Entrectinib-induced heart failure in a patient with metastatic lung adenocarcinoma: A case report. Cureus. 14(12): e32174, 2022.
4. Hara Y, Oshima Y, Tagami Y, Aoki A, Fujii H, Izawa A, Seki K, Kanai A, Yabe A, Watanabe K, Horita N, Kobayashi N, Kaneko T: Clinical importance of serum heme oxygenase-1 measurement in patients with acute exacerbation of idiopathic pulmonary fibrosis triggered by coronavirus disease 2019. Respir Med Case Rep. 36:101615, 2022.
特別講演・教育講演・シンポジウム等
1. 金子 猛: ＜特別講演＞ 将来計画委員会の6年間の活動報告と今後の課題. 第62回日本呼吸器学会学術講演会, 京都, 2022, 4.
2. 金子 猛: ＜教育講演＞ 喀痰分泌の基礎から臨床. 第62回日本呼吸器学会学術講演会, 京都, 2022, 4.
3. 金子 猛: ＜ランチョンセミナー＞ 気道過分泌の観点から見た咳嗽診療. 第62回日本呼吸器学会学術講演会, 京都, 2022, 4.
4. 金子 猛: ＜教育講演＞ＣＯＰＤと呼吸器感染症. 第70回日本化学療法学会総会, 愛知, 2022, 6.
２０２１年度
原著論文
1. Kato H, Takeuchi M, Horita N, Ishido T, Mizuki R, Kawagoe T, Shibuya E, Yuda K, Ishido M, Mizuki Y, Hayashi T, Meguro A, Kirino Y, Minegishi K, Nakano H, Yoshimi R, Kurosawa M, Fukumoto T, Takeno M, Hotta K, Kaneko T, Mizuki N: HLA-A26 is a risk factor for Behçet's disease ocular lesions. Mod Rheumatol. 31(1): 214-218, 2021.
2. Nagasawa R, Hara Y, Murohashi K, Saigusa Y, Nishikawa Y, Tanaka M, Aoki A, Tagami Y, Kobayashi N, Kudo M, Kaneko T: Additional Efficacy of Macrolide for Patients With Acute Deterioration of Interstitial Lung Disease Requiring Corticosteroid Pulse Therapy. Am J Ther. 30(2): 170-173, 2021.
3. Chen H, Horita N, Matsumoto H, Namkoong H, Hara Y, Kobayashi N, Kaneko T: ABO blood group as a risk factor for tuberculosis: a network meta-analysis. Int J Infect Dis. 104: 701-707, 2021.
4. Tateishi Y, Horita N, Namkoong H, Enomoto T, Takeda A, Kaneko T: Postoperative radiotherapy for completely resected Masaoka/Masaoka-Koga stage II/III thymoma improves overall survival: An updated meta-analysis of 4,746 patients. J Thorac Oncol. 16(4): 677-685, 2021.
5. Kobayashi N, Katakura S, Kamimaki C, Somekawa K, Fukuda N, Tanaka K, Watanabe K, Horita N, Hara Y, Piao H, Kaneko T: Resistance mechanisms of epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer patients: A meta-analysis. Thorac Cancer. 12(7): 1096-1105, 2021.
6. Shinoda M, Shinkai M, Hara Y, Tomaru K, Manabe S, Murakami S, Saito H, Kobayashi N, Miyazawa N, Nishikawa M, Kaneko T: Efficacy and safety of carboplatin and pemetrexed followed by maintenance with pemetrexed for elderly patients with advanced non-squamous non-small cell lung cancer: A single-arm, open-label, multicenter, phase II study. Asia Pac J Clin Oncol. 17(6): 486-494, 2021.
7. Horita N, Fukuda N, Kaneko T: Atezolizumab for PD-L1-selected patients with NSCLC. N Engl J Med. 384(6): 583-584, 2021.
8. Ebina-Shibuya R, Namkoong H, Horita N, Kato H, Hara Y, Kobayashi N, Kaneko T: Hydroxychloroquine and chloroquine for treatment of coronavirus disease 19 (COVID-19): a systematic review and meta-analysis of randomized and non-randomized controlled trials. J Thorac Dis. 13(1): 202-212, 2021.
9. Horita N, Katakura S, Kaneko T: Combination treatment options for small-cell lung cancer. Lancet Oncol. 22(3): e83, 2021.
10. Kubo S, Ohtake N, Miyakawa K, Jeremiah SS, Yamaoka Y, Murohashi K, Hagiwara E, Mihara T, Goto A, Yamazaki E, Ogura T, Kaneko T, Yamanaka T, Ryo A: Development of an Automated Chemiluminescence Assay System for Quantitative Measurement of Multiple Anti-SARS-CoV-2 Antibodies. Front Microbiol. 11: 628281, 2021.
11. Chen H, Hara Y, Horita N, Saigusa Y, Kaneko T: An Early Screening Tool for Discharge Planning Shortened Length of Hospital Stay for Elderly Patients with Community-Acquired Pneumonia. Clin Interv Aging. 16: 443-450, 2021.
12. Ishii M, Horita N, Takeuchi M, Matsumoto H, Ebina-Shibuya R, Hara Y, Kobayashi N, Mizuki N, Kaneko T: Inhaled Corticosteroid and Secondary Glaucoma: A Meta-analysis of 18 Studies. Allergy Asthma Immunol Res. 13(3): 435-449, 2021.
13. Oshikata C, Watanabe M, Ishida M, Kobayashi S, Hashimoto K, Kobayashi N, Yamazaki A, Konuma R, Kaneko T, Kamata Y, Kuriyama S, Yanai M, Tsurikisawa N: Association between Temporary Housing Habitation after the 2011 Japan Earthquake and Mite Allergen Sensitization and Asthma Development. Int Arch Allergy Immunol. 182(10): 949-961, 2021.
14. Tsurikisawa N, Oshikata C, Watanabe M, Fukuda N, Yamaguchi T, Kiyohara H, Kaneko T: Clinical Features of Patients with Active Eosinophilic Granulomatosis with Polyangiitis Successfully Treated with Mepolizumab. Int Arch Allergy Immunol. 182(8): 744-756, 2021.
15. Tateishi Y, Takeda A, Horita N, Tsurugai Y, Eriguchi T, Kibe Y, Sanuki N, Kaneko T: Stereotactic body radiotherapy with a high maximum dose improves local control, cancer-specific death and overall survival in peripheral early-stage non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 111(1): 143-151, 2021.
16. Kamimaki C, Kobayashi N, Hirata M, Somekawa K, Fukuda N, Kubo S, Katakura S, Teranishi S, Watanabe K, Horita N, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T: T-cell response to phytohemagglutinin in the interferon-γ release assay as a potential biomarker for the response to immune checkpoint inhibitors in patients with non-small cell lung cancer. Thorac Cancer. 12(11): 1726-1734, 2021.
17. 原 悠, 稲森 正彦, 青木 絢子, 田上 陽一, 中島 健太郎, 渡邉 恵介, 堀田 信之, 小林 信明, 金子 猛: 病棟実習の代替教育ツールとしてのオンライン方式JABSOM PBLの実践 横浜市立大学医学部における試み. 横浜医学, 72(2): 89-92, 2021.
18. 高橋 浩一郎, 小林 信明, 浅井 一久, 礒部 威, 今泉 和良, 大平 徹郎, 長内 忍, 川山 智隆, 國近 尚美, 小林 和幸, 佐野 博幸, 多賀谷 悦子, 千葉 弘文, 橋本 直純, 須田 隆文, 金子 猛: 日本呼吸器学会会員における大学院進学に関する最近の動向. 日本呼吸器学会誌, 10(3): 207-211, 2021.
19. 小林 信明, 高橋 浩一郎, 浅井 一久, 礒部 威, 今泉 和良, 大平 徹郎, 長内 忍, 川山 智隆, 國近 尚美, 小林 和幸, 佐野 博幸, 多賀谷 悦子, 千葉 弘文, 橋本 直純, 須田 隆文, 金子 猛, 日本呼吸器学会将来計画委員会: 呼吸器内科医師の海外留学に関するアンケート調査. 日本呼吸器学会誌, 10(2): 102-107, 2021.
英文総説
20. Hara Y, Nakashima K, Nagasawa R, Murohashi K, Tagami Y, Aoki A, Okudela K, Kaneko T: Heme oxygenase-1 in patients with interstitial lung disease: A review of the clinical evidence. Am J Med Sci. 362(2): 122-129, 2021.
邦文総説
21. 原 悠, 金子 猛: 【慢性咳嗽-古い症状・新しい知見】咳のメカニズム. カレントテラピー, 39(8): 700-704, 2021.
22. 原 悠, 長澤 遼, 田上 陽一, 金子 猛: 【内科医に必要な呼吸器診療のコツ】咳嗽・喀痰の診かたと薬物療法. 日本内科学会雑誌, 110(6): 1063-1070, 2021.
23. 田上 陽一, 原 悠, 金子 猛: コロナ禍におけるCOPDの管理. 呼吸器内科, 3(3): 259-264, 2021.
24. 長澤 遼, 原 悠, 金子 猛: COPDの増悪の治療. 呼吸器内科, 39(2): 136-141, 2021.
25. 金子 猛: 【リハビリテーション診療の現場で悩む呼吸トラブル対策】喀痰障害 喀痰を生じる病態と喀痰診療のポイント. MEDICAL REHABILITATIO, 25: 17-22, 2021.
学会発行診療ガイドライン等
1. 金子 猛(作成委員):日本アレルギー学会 喘息ガイドライン専門部会監. 喘息予防・管理ガイドライン2021. 東京：協和企画：2021.
2. Takeshi Kaneko (Member of the Guideline Development Committee): The Japanese respiratory society guidelines for the management of cough and sputum (digest edition). JRS guidelines committee for the management of cough and sputum (Mukae H, Kaneko T, Obase Y, Shinkai M, Katsunuma T, Takeyama K, Terada J, Niimi A, Matsuse H, Yatera K, Yamamoto Y, Azuma A, Arakawa H, Iwanaga T, Ogawa H, Kurahashi K, Gon Y, Sakamoto H, Shibata Y, Tamada T, Nishioka Y, Haranaga S, Fujieda S, Miyashita N, Mochizuki H, Yokoyama A, Yoshihara S, Tamaoki J). Respir Investig. 59(3): 270-290, 2021.
著書
1. 金子 猛:インフルエンザ. 今日の治療指針2021. 医学書院, 211-215, 2021.
症例報告
1. 庄内 志織, 長澤 遼, 原 悠, 橋本 恒, 奥寺 康司, 金子 猛: 喫煙関連間質性肺炎様変化を示した関節リウマチの2例. 日本呼吸器学会誌, 10(6): 487-493, 2021.
2. 橋本 恒, 渡邉 恵介, 三宅 暁夫, 田中 克志, 中島 健太郎, 原 悠, 小林 信明, 金子 猛: 尋常性乾癬に合併した器質化肺炎が疑われた1例. 気管支学, 4(2): 112-116, 2021.
3. 荻窪 まどか, 伊坂 哲哉, 石川 善啓, 禹 哲漢, 利野 靖, 益田 宗孝, 松村 舞依, 奥寺 康司, 小林 信明, 金子 猛: 高齢者の肺Combined Large-Cell Neuroendocrine Carcinoma術後再発にアムルビシン単独投与の有効性が認められた1例. 癌と化学療法, 4(5): 681-683, 2021.
4. 木村 泰浩, 鄭 慶鎬, 佐渡 怜子, 宮沢 直幹, 金子 猛: ダサチニブによる薬剤性肺障害の1例. 日本呼吸器学会誌, 10(3): 277-282, 2021.
5. 橋本 恒, 小泉 晴美, 金子 彩美, 藤井 裕明, 亀井 克彦, 金子 猛: 多剤併用療法で改善を得たAspergillus tubingensisによる慢性進行性肺アスペルギルス症の1例. 日本呼吸器学会誌, 10(2): 158-162, 2021.
特別講演・教育講演・シンポジウム等
1. 金子 猛: ＜特別講演＞ Unmet needs in airway hypersecretion. 第61回日本呼吸器学会学術講演会, 東京, 2021, 4.
新聞・雑誌・テレビ
1. 金子 猛: 読売新聞 2021年5月9日朝刊 特集記事「呼吸の日 Withコロナ時代のぜん息治療～医師からのアドバイス～」
２０２０年度
原著論文
1. Mizuki Y, Horita N, Horie Y, Takeuchi M, Ishido T, Mizuki R, Kawagoe T, Shibuya E, Yuda K, Ishido M, Minegishi K, Yoshimi R, Kirino Y, Kato S, Arimoto J, Fukumoto T, Kurosawa M, Kitaichi N, Takeno M, Kaneko T, Mizuki N: The influence of HLA-B51 on clinical manifestations among Japanese patients with Behçet's disease: A nationwide survey. Mod Rheumatol, 30(4): 708-714, 2020.
2. Teranishi S, Kobayashi N, Aoki A, Katakura S, Yamamoto M, Koizumi H, Kudo M, Kaneko T: Reproducibility of the T-SPOT.TB test for screening Mycobacterium tuberculosis infection in Japan. J Infect Chemother, 26(2): 194-198, 2020.
3. Teranishi S, Kobayashi N, Katakura S, Kamimaki C, Kubo S, Shibata Y, Yamamoto M, Kudo M, Piao H, Kaneko T: Class A CpG oligodeoxynucleotide inhibits IFN-γ-induced signaling and apoptosis in lung cancer. Thorac Cancer, 11(4): 983-992, 2020.
4. Shibata Y, Kobayashi N, Sato T, Nakashima K, Kaneko T: The clinical significance of CXCL16 in the treatment of advanced non-small cell lung cancer. Thorac Cancer, 11(5): 1258-1264, 2020.
5. Horita N, Kaneko T: Thrombomodulin Did Not Benefit Acute Exacerbation of Idiopathic Pulmonary Fibrosis in a Trial. Am J Respir Crit Care Med, 202(1): 150-151, 2020.
6. Sakono T, Meguro A, Takeuchi M, Yamane T, Teshigawara T, Kitaichi N, Horie Y, Namba K, Ohno S, Nakao K, Sakamoto T, Sakai T, Nakano T, Keino H, Okada AA, Takeda A, Ito T, Mashimo H, Ohguro N, Oono S, Enaida H, Okinami S, Horita N, Ota M, Mizuki N: Variants in IL23R-C1orf141 and ADO-ZNF365-EGR2 are associated with susceptibility to Vogt-Koyanagi-Harada disease in Japanese population. PLoS One, 15(5): e0233464, 2020.
7. Kobayashi N, Hashimoto H, Kamimaki C, Nagasawa R, Tanaka K, Kubo S, Katakura S, Chen H, Hirama N, Ushio R, Aoki A, Nakashima K, Teranishi S, Manabe S, Watanabe H, Horita N, Watanabe K, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T: Afatinib + bevacizumab combination therapy in EGFR-mutant NSCLC patients with osimertinib resistance: Protocol of an open-label, phase II, multicenter, single-arm trial. Thorac Cancer, 11(8): 2125-2129, 2020.
8. Ebina-Shibuya R, Horita N, Namkoong H, Kaneko T: National policies for paediatric universal BCG vaccination were associated with decreased mortality due to COVID-19. Respirology, 25(8): 898-899, 2020.
9. Manabe S, Kasajima R, Murakami S, Miyagi Y, Yokose T, Kondo T, Saito H, Ito H, Kaneko T, Yamada K: Analysis of targeted somatic mutations in pleomorphic carcinoma of the lung using next-generation sequencing technique. Thorac Cancer, 11(8): 2262-2269, 2020.
10. Kubo S, Kobayashi N, Somekawa K, Hirata M, Kamimaki C, Aiko H, Katakura S, Teranishi S, Watanabe K, Hara Y, Yamamoto M, Kudo M, Kaneko T: Identification of Biomarkers for Non-small-cell Lung Cancer Patients Treated With an Immune Checkpoint Inhibitor. Anticancer Res, 40(7): 3889-3896, 2020.
11. Ebina-Shibuya R, Horita N, Namkoong H, Kaneko T: Current national policies for infant universal bacille Calmette-Guérin vaccination were associated with lower mortality from coronavirus disease 2019. Clin Exp Vaccine Res, 9(2): 179-182, 2020.
12. Murohashi K, Hagiwara E, Kitayama T, Yamaya T, Higa K, Sato Y, Otoshi R, Shintani R, Okabayashi H, Ikeda S, Niwa T, Nakazawa A, Oda T, Okuda R, Sekine A, Kitamura H, Baba T, Komatsu S, Iwasawa T, Kaneko T, Ogura T: Outcome of early-stage combination treatment with favipiravir and methylprednisolone for severe COVID-19 pneumonia: A report of 11 cases. Respir Investig, 58(6): 430-434, 2020.
13. Katakura S, Kobayashi N, Hashimoto H, Kamimaki C, Tanaka K, Kubo S, Nakashima K, Teranishi S, Manabe S, Watanabe K, Horita N, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T: MicroRNA-200b is a potential biomarker of the expression of PD-L1 in patients with lung cancer. Thorac Cancer, 11(10):2975-2982, 2020.
14. Chen H, Hara Y, Horita N, Saigusa Y, Hirai Y, Kaneko T: Declined Functional Status Prolonged Hospital Stay for Community-Acquired Pneumonia in Seniors. Clin Interv Aging, 15: 1513-1519, 2020.
15. Chen H, Horita N, Ito K, Hara Y, Kobayashi N, Kaneko T: Hazard ratio of progression-free survival is an excellent predictor of overall survival in phase III randomized controlled trials evaluating the first-line chemotherapy for extensive-disease small-cell lung cancer. Transl Lung Cancer Res, 9(4): 1333-1342, 2020.
16. Katakura S, Kobayashi N, Hashimoto H, Kamimaki C, Tanaka K, Kubo S, Nakashima K, Teranishi S, Watanabe K, Hara Y, Yamamoto M, Kudo M, Piao H, Kaneko T: Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in Japan. Tuberculosis (Edinb), 125: 101992, 2020.
17. Yumoto K, Sato T, Nakashima K, Namai F, Shigemori S, Shimosato T, Kaneko T: Nasally Administered Lactococcus lactis Secreting Heme Oxygenase-1 Attenuates Murine Emphysema. Antioxidants (Basel), 9(11): 1049, 2020.
18. Watanabe K, Asai Y, Tsurikisawa N, Oshikata C, Kaneko T: Factors associated with pneumococcal vaccine uptake in elderly subjects referred to the respiratory department. Nagoya J Med Sci, 82(3): 469-476, 2020.
19. Sasaki H, Hara Y, Taguri M, Fujikura Y, Murohashi K, Yagyu H, Kaneko T, Kawana A: Serum surfactant protein A as a surrogate biomarker of a negative heart sign among patients with interstitial lung disease. Nagoya J Med Sci, 82(3): 499-508, 2020.
20. Yagyu H, Murohashi K, Hara Y, Saigusa Y, Aoki A, Kobayashi N, Kaneko T: Clinical utility of a composite scoring system including Charlson Comorbidity Index score in patients with interstitial lung disease. J Thorac Dis, 12(10): 5774-5782, 2020.
21. Nagasawa R, Hara Y, Murohashi K, Aoki A, Kobayashi N, Takagi S, Hashimoto S, Kawana A, Kaneko T: Serum heme oxygenase-1 measurement is useful for evaluating disease activity and outcomes in patients with acute respiratory distress syndrome and acute exacerbation of interstitial lung disease. BMC Pulm Med, 20(1): 310, 2020.
22. Horita N, Chen H, Kaneko T: Carboplatin plus etoposide for sensitive relapsed small-cell lung cancer. Lancet Oncol, 21(12): e545, 2020.
23. Chen H, Horita N, Ito K, Nagakura H, Hara Y, Kobayash N, Yamamoto M, Kudo M, Kaneko T: Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysis. Ther Adv Med Oncol, 12: 1758835920965841, 2020.
1. 今泉 和良, 山谷 睦雄, 須田 隆文, 礒部 威, 大平 徹郎, 長内 忍, 川山 智隆, 國近 尚美, 佐野博幸, 柴田陽光, 新海正晴, 多賀谷悦子, 千葉弘文, 松本久子, 金子 猛, 日本呼吸器学会将来計画委員会: わが国の呼吸器臨床病理の現状と問題点 病理医のアンケート結果より. 日本呼吸器学会誌, 9(5): 311-318, 2020.
2. 鎌田啓佑, 今野 哲, 金子 猛, 福永興壱, 長谷川好規, 横山彰仁: 新型コロナウイルス感染症診療における呼吸器内科医師の活動実態に関するアンケート調査結果. 日本呼吸器学会誌, 9(4): 233-238, 2020.
邦文総説
1. 金子 猛: よく使う日常治療薬の正しい使い方 COPD治療薬の正しい使い方. レジデントノート, 22(3): 573-577, 2020.
2. 金子 猛: 【呼吸器病学TOPICS 2019-20】臨床諸問題 咳嗽・喀痰の診療ガイドライン2019のポイント. 特集: 分子呼吸器病, 24(1): 51-58, 2020.
3. 金子 猛: 差分解説 「咳嗽・喀痰のガイドライン2019」を読み解く②. 日本医事新報, 5003: 52, 2020.
4. 金子 猛: 【喘息とCOPD】知っておいてほしいサブタイプと肺の併存疾患 喘息とCOPDのオーバーラップ(ACO). 内科(6), 125: 1379-1384, 2020.
5. 金子 猛: 【増加する日中における呼吸器疾患の研究と臨床Update】COPD 日本における研究と診療の最前線. 日中医学, 35(1): 14-18, 39-43, 2020.
6. 金子 猛：ガイドライン ココだけおさえる 「咳嗽・喀痰の診療ガイドライン2019」. 日本医事新報, 5030: 31-35, 2020.
7. 金子 猛: 【咳嗽の臨床】副鼻腔気管支症候群. 日本内科学会誌, 109(10): 2132-2136, 2020.
8. 原 悠, 金子 猛: 差分解説 急性呼吸窮迫症候群, 間質性肺炎急性増悪における新規血清バイオマーカー確立の試み．日本医事新報, 5029: 47, 2020.
著書
1. 金子 猛: ノカルジア症. 今日の治療指針2020. 医学書院, 224-225, 2020.
2. 金子 猛: 第Ⅱ章 呼吸器疾患「咳嗽・喀痰」. 日常診療に活かす診療ガイドラインUP-TO-DATE 2020-2021. メディカルレビュー社, 58-90, 2020.
3. 金子 猛: 胸水貯留. 今日の診断指針 第8版. 医学書院, 349-354, 2020.
4. 金子 猛: 百日咳. 新臨床内科学 第10版. 医学書院, 1563-1564, 2020.
5. 金子 猛: レジオネラ症（在郷軍人病）. 新臨床内科学 第10版. 医学書院, 1564-1566, 2020.
6. 金子 猛: 鎮咳薬, 喀痰調整薬（去痰薬）. 新呼吸器専門医テキスト［改訂第2版］. 南江堂, 184-185, 2020.
7. 青木絢子, 原 悠, 金子 猛: アレルギー性気管支肺アスペルギルス症. 最新ガイドラインに基づく呼吸器疾患 診療指針2021-'22. 総合医学社, 198-205, 2020.
症例報告
1. Ueki Y, Oshikata C, Asai Y, Kaneko T, Tsurikisawa N: Familial Eosinophilic Granulomatosis with Polyangiitis in a Sister and Brother. Intern Med, 59(7): 991-995, 2020.
2. Murohashi K, Hara Y, Aoki A, Matsumura M, Kataoka T, Okudela K, Kaneko T: Diffuse alveolar hemorrhage complicating acute exacerbation of IPF. Respir Med Case Rep, 29: 101022, 2020.
3. Matsumoto S, Watanabe K, Kobayashi N, Irie K, Yamanaka S, Kaneko T: Pembrolizumab-induced secondary sclerosing cholangitis in a non-small cell lung cancer patient. Respirol Case Rep, 8(5): e00560, 2020.
4. Shinagawa K, Oshikata C, Kaneko T, Tsurikisawa N: A case of lactoferrin-induced occupational asthma. J Allergy Clin Immunol Pract, 8(10): 3600-3602, 2020.
5. Nagasawa R, Hara Y, Miyazaki T, Murohashi K, Watanabe H, Kaneko T: An autopsy case of ventilator-associated tracheobronchitis caused by Corynebacterium species complicated with diffuse alveolar damage. Respir Med Case Rep, 31: 101208, 2020.
6. Aoki A, Hara Y, Okudela K, Ishikawa Y, Doshita K, Hashimoto H, Nakashima K, Horita N, Kobayashi N, Kaneko T: Unusual lung involvements of invasive mucinous adenocarcinoma with chylothorax. Thorac Cancer, 11(11): 3407-3408, 2020.
7. 伊藤俊輔, 大塚 葵, 石井宏志, 西平隆一, 平居義裕, 長澤 遼, 井上 玲, 陳 昊, 金子 猛: オシメルチニブにより著明な駆出率低下と心不全を認めた1例. 癌と化学療法, 47(4): 609-613, 2020.
8. 伊藤 悠, 伊藤 優, 原 悠, 髙橋良平, 角田幸雄, 金子 猛: 人工血管アスペルギルス感染症の1剖検例：文献レビューからの臨床像の考察. 日本呼吸器学会誌, 9(1): 23-27, 2020.
9. 伊藤 悠, 伊藤 優, 川島英俊, 山本健嗣, 金子 猛, 角田幸雄, 前原孝光: 転移性肺腫瘍の原発巣の鑑別を要し組織所見を経時的に観察し得た肺癌・直腸癌の重複癌の症例. 肺癌, 60(2): 109-114, 2020.
10. 加藤英明, 渡邊弘樹, 小林信明, 原 悠, 酒井和也, 中嶋賢人, 小川史洋, 佐野加代子, 山崎悦子, 宇宿修三, 田中伸子, 竹内一郎, 中島秀明, 金子 猛: SARS-CoV-2 PCR検査が長期陽性持続した新型コロナウイルス感染症(COVID-19)の2例. 感染症学雑誌, 94(4): 591-595, 2020.
11. 張田佳代, 原 悠, 室橋光太, 長澤 遼, 奥寺康司, 金子 猛: 血清ヘムオキシゲナーゼ-1が病勢と連動したアビラテロン酢酸エステルによる薬剤性肺障害の1例. 日本呼吸器学会誌, 9(2): 141-146, 2020.
シンポジウム・教育講演等
1. 金子 猛: ＜教育講演＞ COPDにおける気道分泌病態について. 第60回日本呼吸器学会学術講演会（Web開催）, 2020, 9.
新聞・雑誌・テレビ等
1. 金子 猛: お医者さんオンライン（Webサイト） 咳: 原因は？喘息ででる咳は？病院受診のタイミングは？咳止めの効果は？ 2020年11月公開.
2. 原 悠, 金子 猛: お医者さんオンライン（Webサイト） 血痰: どんな病気が原因になる？血痰に伴う心配な症状は？病院受診のタイミングは？ 2020年11月公開.